Plus Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.94
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.20
|
-0.19
|
0.01
|
5.00%
|
|
2022-06-30
|
-0.22
|
-0.24
|
-0.02
|
-9.09%
|
|
2022-03-31
|
-0.18
|
-0.19
|
-0.01
|
-5.56%
|
|
2021-12-31
|
-0.27
|
-0.27
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.24
|
-0.28
|
-0.04
|
-16.67%
|
|
2021-06-30
|
-0.24
|
-0.25
|
-0.01
|
-4.17%
|
|
2021-03-31
|
-0.34
|
-0.33
|
0.01
|
2.94%
|
|
2020-12-31
|
-0.39
|
-0.67
|
-0.28
|
-71.79%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.62
|
|
2021-12-31
|
-1.13
|
|
2020-12-31
|
-1.79
|
|
2019-12-31
|
-13.92
|
|
2018-12-31
|
-100.05
|
|
2017-12-31
|
-218.30
|
|
2016-12-31
|
-9.70
|
|
2015-12-31
|
-3.00
|
|
2014-12-31
|
-2178.00
|
|
2013-12-31
|
-3300.00
|
|
2012-12-31
|
-4050.00
|
|
2011-12-31
|
-4500.00
|
|
2010-12-31
|
-4425.00
|
|
2009-12-31
|
-4800.00
|
|
2008-12-31
|
-8475.00
|
|
2007-12-31
|
-9465.63
|
|
2006-12-31
|
-11843.60
|
|
2005-12-31
|
-12527.98
|
|
2003-12-31
|
-2027.38
|